{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:59:55Z","timestamp":1789721995815,"version":"4.0.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T00:00:00Z","timestamp":1596326400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatol. Commun."],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:p>Chronic Liver Disease (CLD) is associated with an increased risk of chronic kidney disease (CKD). However, the health care burden of CKD in the CLD spectrum is unknown. We aimed to evaluate the health care use and cost burdens associated with CKD in patients with CLD in the United States by using real\u2010world claims data. We analyzed data from the Truven Health MarketScan Commercial Claims database from 2010 to 2015. A total of 19,664 patients with CLD with or without comorbid CKD were identified using International Classification of Diseases, Ninth Revision, codes and matched 1:1 by sociodemographic characteristics and comorbidities using propensity scores. Total and service\u2010specific unadjusted and adjusted health care parameters were analyzed for the 12\u00a0months following an index date selected at random to capture whole disease burdens. In CLD, comorbid CKD was associated with a higher annual number of claims per person (CKD vs. no CKD, 69 vs. 55) and higher total annual median health care costs (CKD vs. no CKD, $21,397 vs. $16,995). A subanalysis stratified by CKD category showed that health care use and cost burden in CLD increased with disease stage, with a peak 12\u2010month median cost difference of $77,859 in patients on dialysis. The adjusted per person annual health care cost was higher for CKD cases compared to controls ($35,793 vs. $24,048, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0&lt;\u00a00.0001). Stratified by the type of CLD, the highest between\u2010group adjusted cost differences were for cirrhosis, viral hepatitis, hemochromatosis, and nonalcoholic fatty liver disease. <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic> CKD is a cost multiplier in CLD. The CKD health care burden in liver disease differs by the type of CLD. Improved CKD screening and proactive treatment interventions for at\u2010risk patients can limit the excess burden associated with CKD in patients with CLD.<\/jats:p>","DOI":"10.1002\/hep4.1573","type":"journal-article","created":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T10:05:11Z","timestamp":1596362711000},"page":"1404-1418","source":"Crossref","is-referenced-by-count":13,"title":["Health Care Resource Use and Cost Burden of Chronic Kidney Disease in Patients With Chronic Liver Disease: A Real\u2010World Claims Analysis"],"prefix":"10.1097","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4105-5783","authenticated-orcid":false,"given":"Vinod K.","family":"Rustgi","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Rutgers Robert Wood Johnson Medical School,New Brunswick,NJ,USA"},{"name":"Center for Liver Diseases and Masses,Rutgers Robert Wood Johnson Medical School,New Brunswick,NJ,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Rutgers Robert Wood Johnson Medical School,New Brunswick,NJ,USA"},{"name":"Center for Liver Diseases and Masses,Rutgers Robert Wood Johnson Medical School,New Brunswick,NJ,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4506-1275","authenticated-orcid":false,"given":"Tina","family":"John","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Rutgers Robert Wood Johnson Medical School,New Brunswick,NJ,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Catalano","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Rutgers Robert Wood Johnson Medical School,New Brunswick,NJ,USA"},{"name":"Center for Liver Diseases and Masses,Rutgers Robert Wood Johnson Medical School,New Brunswick,NJ,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7963-2438","authenticated-orcid":false,"given":"Mohamed I.","family":"Elsaid","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Rutgers Robert Wood Johnson Medical School,New Brunswick,NJ,USA"},{"name":"Center for Liver Diseases and Masses,Rutgers Robert Wood Johnson Medical School,New Brunswick,NJ,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,2]]},"reference":[{"key":"hep41573-bib-0001-20240114","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","year":"2019","journal-title":"J Hepatol"},{"key":"hep41573-bib-0002-20240114","article-title":"Trends in the burden of chronic liver disease among hospitalized US adults","volume":"3","year":"2020","journal-title":"JAMA Netw Open"},{"key":"hep41573-bib-0003-20240114","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cgh.2016.07.020","article-title":"Direct and indirect economic burden of chronic liver disease in the United States","volume":"15","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep41573-bib-0004-20240114","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/hep.30094","article-title":"Healthcare cost and utilization in nonalcoholic fatty liver disease: real\u2010world data from a large U.S. claims database","volume":"68","year":"2018","journal-title":"Hepatology"},{"key":"hep41573-bib-0005-20240114","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep41573-bib-0006-20240114","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cld.2015.10.005","article-title":"The prevalence and pathobiology of nonalcoholic fatty liver disease in patients of different races or ethnicities","volume":"20","year":"2016","journal-title":"Clin Liver Dis"},{"key":"hep41573-bib-0007-20240114","first-page":"1573","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","year":"2016","journal-title":"Hepatology"},{"key":"hep41573-bib-0008-20240114","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20102013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","year":"2014","journal-title":"Lancet"},{"key":"hep41573-bib-0009-20240114","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","year":"2005","journal-title":"Kidney Int"},{"key":"hep41573-bib-0011-20240114","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/kisup.2013.79","article-title":"Risk factors for chronic kidney disease: an update","volume":"3","year":"2013","journal-title":"Kidney Int Suppl (2011)"},{"key":"hep41573-bib-0012-20240114","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/s12913-017-2303-3","article-title":"Trends in healthcare expenditure in United States adults with chronic kidney disease: 2002\u20102011","volume":"17","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"hep41573-bib-0013-20240114","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2753.2007.00883.x","article-title":"Economic burden of chronic kidney disease","volume":"14","year":"2008","journal-title":"J Eval Clin Pract"},{"key":"hep41573-bib-0014-20240114","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1186\/s12913-016-1922-4","article-title":"Assessing key cost drivers associated with caring for chronic kidney disease patients","volume":"16","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"hep41573-bib-0015-20240114","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/dc15-1182","article-title":"Fatty liver and chronic kidney disease: novel mechanistic insights and therapeutic opportunities","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"hep41573-bib-0016-20240114","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/pgmj.2009.092775","article-title":"Chronic viral hepatitis and chronic kidney disease","volume":"86","year":"2010","journal-title":"Postgrad Med J"},{"key":"hep41573-bib-0017-20240114","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1093\/ndt\/gfl247","article-title":"Chronic kidney disease post\u2010liver transplantation","volume":"21","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"hep41573-bib-0018-20240114","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1377\/hlthaff.2015.0600","article-title":"National health expenditure projections, 2014\u201024: spending growth faster than recent trends","volume":"34","year":"2015","journal-title":"Health Aff (Millwood)"},{"key":"hep41573-bib-0019-20240114","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD\u20109\u2010CM and ICD\u201010 administrative data","volume":"43","year":"2005","journal-title":"Med Care"},{"key":"hep41573-bib-0021-20240114","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.transproceed.2008.03.099","article-title":"The burden of chronic kidney disease in long\u2010term liver transplant recipients","volume":"40","year":"2008","journal-title":"Transplant Proc"},{"key":"hep41573-bib-0022-20240114","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000454684","article-title":"Impact of renal disease on patients with hepatitis C: a retrospective analysis of disease burden, clinical outcomes, and health care utilization and cost","volume":"136","year":"2017","journal-title":"Nephron"},{"key":"hep41573-bib-0023-20240114","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s40261-017-0526-z","article-title":"Disease burden, early discontinuation, and healthcare costs in hepatitis C patients with and without chronic kidney disease treated with interferon\u2010free direct\u2010acting antiviral regimens","volume":"37","year":"2017","journal-title":"Clin Drug Investig"},{"key":"hep41573-bib-0024-20240114","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12882-016-0432-2","article-title":"Non\u2010dialysis dependent chronic kidney disease is associated with high total and out\u2010of\u2010pocket healthcare expenditures","volume":"18","year":"2017","journal-title":"BMC Nephrol"},{"key":"hep41573-bib-0025-20240114","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.diabres.2015.04.011","article-title":"Medical care expenditures associated with chronic kidney disease in adults with diabetes: United States 2011","volume":"109","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"hep41573-bib-0026-20240114","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/1078155218766408","article-title":"Healthcare resource use and costs associated with chronic kidney disease in US private insurance patients with multiple myeloma","volume":"25","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"hep41573-bib-0027-20240114","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000213166","article-title":"Healthcare expenditure and resource utilization in patients with anaemia and chronic kidney disease: a retrospective claims database analysis","volume":"32","year":"2009","journal-title":"Kidney Blood Press Res"},{"key":"hep41573-bib-0028-20240114","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1681\/ASN.2012040392","article-title":"Medical costs of CKD in the Medicare population","volume":"24","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"hep41573-bib-0029-20240114","first-page":"k2817","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999\u20102016: observational study","volume":"362","year":"2018","journal-title":"BMJ"},{"key":"hep41573-bib-0030-20240114","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00005650-198701000-00004","article-title":"Cost\u2010effectiveness analysis of end\u2010stage renal disease treatments","volume":"25","year":"1987","journal-title":"Med Care"},{"key":"hep41573-bib-0031-20240114","first-page":"2838","article-title":"Hemodialysis and transplantation cost\u2010effectiveness analysis","volume":"28","year":"1996","journal-title":"Transplant Proc"},{"key":"hep41573-bib-0032-20240114","article-title":"Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis\u2010a US population\u2010based study","year":"2020","journal-title":"J Hepatol"},{"key":"hep41573-bib-0033-20240114","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/lt.25694","article-title":"Chronic kidney disease in liver transplant candidates: a rising burden impacting post\u2010liver transplant outcomes","volume":"26","year":"2020","journal-title":"Liver Transpl"},{"key":"hep41573-bib-0034-20240114","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non\u2010alcoholic fatty liver disease \u2010 A global public health perspective","volume":"70","year":"2019","journal-title":"J Hepatol"},{"key":"hep41573-bib-0035-20240114","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease","volume":"23","year":"2017","journal-title":"World J Gastroenterol"},{"key":"hep41573-bib-0036-20240114","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.30254","article-title":"Burden of illness and economic model for patients with nonalcoholic steatohepatitis in the United States","volume":"69","year":"2019","journal-title":"Hepatology"}],"container-title":["Hepatology Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep4.1573","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep4.1573","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep4.1573","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep4.1573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T16:14:29Z","timestamp":1705248869000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep4.1573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,2]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1002\/hep4.1573","relation":{},"ISSN":["2471-254X","2471-254X"],"issn-type":[{"value":"2471-254X","type":"print"},{"value":"2471-254X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,2]]}}}